Meyka Pro banner
MaxLinear, Inc.

MaxLinear, Inc. Fundamental Analysis (NASDAQ: MXL)

MXLNASDAQ
TechnologySemiconductors
$73.19
$6.37(9.53%)
U.S. Market is Open · 14:42

MaxLinear, Inc. Fundamental Analysis (NASDAQ: MXL)

MaxLinear, Inc. (NASDAQ: MXL) shows moderate financial fundamentals with a PE ratio of -56.88, profit margin of -18.24%, and ROE of -22.37%. The company generates $0.6B in annual revenue with strong year-over-year growth of 29.71%.

Key Strengths

PEG Ratio-0.70
Current Ratio1.78

Areas of Concern

ROE-22.37%
Operating Margin-11.57%
Cash Position1.09%
We analyze MXL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 10.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
10.0/100

We analyze MXL's fundamental strength across five key dimensions:

Efficiency Score

Weak

MXL struggles to generate sufficient returns from assets.

ROA > 10%
-12.61%

Valuation Score

Excellent

MXL trades at attractive valuation levels.

PE < 25
-56.88
PEG Ratio < 2
-0.70

Growth Score

Excellent

MXL delivers strong and consistent growth momentum.

Revenue Growth > 5%
29.71%
EPS Growth > 10%
46.08%

Financial Health Score

Excellent

MXL maintains a strong and stable balance sheet.

Debt/Equity < 1
0.29
Current Ratio > 1
1.78

Profitability Score

Weak

MXL struggles to sustain strong margins.

ROE > 15%
-2236.60%
Net Margin ≥ 15%
-18.24%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is MXL Expensive or Cheap?

P/E Ratio

MXL trades at -56.88 times earnings. This suggests potential undervaluation.

-56.88

PEG Ratio

When adjusting for growth, MXL's PEG of -0.70 indicates potential undervaluation.

-0.70

Price to Book

The market values MaxLinear, Inc. at 12.40 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

12.40

EV/EBITDA

Enterprise value stands at -151.23 times EBITDA. This is generally considered low.

-151.23

How Well Does MXL Make Money?

Net Profit Margin

For every $100 in sales, MaxLinear, Inc. keeps $-18.24 as profit after all expenses.

-18.24%

Operating Margin

Core operations generate -11.57 in profit for every $100 in revenue, before interest and taxes.

-11.57%

ROE

Management delivers $-22.37 in profit for every $100 of shareholder equity.

-22.37%

ROA

MaxLinear, Inc. generates $-12.61 in profit for every $100 in assets, demonstrating efficient asset deployment.

-12.61%

Following the Money - Real Cash Generation

Operating Cash Flow

MaxLinear, Inc. generates limited operating cash flow of $16.81M, signaling weaker underlying cash strength.

$16.81M

Free Cash Flow

MaxLinear, Inc. generates weak or negative free cash flow of $3.38M, restricting financial flexibility.

$3.38M

FCF Per Share

Each share generates $0.04 in free cash annually.

$0.04

FCF Yield

MXL converts 0.05% of its market value into free cash.

0.05%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-56.88

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.70

vs 25 benchmark

P/B Ratio

Price to book value ratio

12.40

vs 25 benchmark

P/S Ratio

Price to sales ratio

10.79

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.29

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.78

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.22

vs 25 benchmark

ROA

Return on assets percentage

-0.13

vs 25 benchmark

ROCE

Return on capital employed

-0.10

vs 25 benchmark

How MXL Stacks Against Its Sector Peers

MetricMXL ValueSector AveragePerformance
P/E Ratio-56.8835.65 Better (Cheaper)
ROE-22.37%651.00% Weak
Net Margin-18.24%-138740.00% (disorted) Weak
Debt/Equity0.290.26 Neutral
Current Ratio1.785.96 Neutral
ROA-12.61%227.00% Weak

MXL outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews MaxLinear, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-17.47%

Industry Style: Growth, Innovation, High Beta

Declining

EPS CAGR

-17.09%

Industry Style: Growth, Innovation, High Beta

Declining

FCF CAGR

-77.48%

Industry Style: Growth, Innovation, High Beta

Declining

Fundamental Analysis FAQ